Literature DB >> 7963107

Abnormal coronary flow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: implication for tachycardia-induced myocardial ischemia.

T Masuyama1, M Uematsu, Y Doi, K Yamamoto, T Mano, J Naito, H Kondo, R Nagano, M Hori, T Kamada.   

Abstract

OBJECTIVES: This study attempted to clarify the effect of ventricular relaxation abnormalities on coronary flow dynamics at rest and during tachycardia in humans.
BACKGROUND: Ventricular relaxation abnormality has been demonstrated in animals to have an adverse impact on early diastolic coronary flow dynamics. However, this relation has not been established in humans. Even if the adverse effect were latent at rest, it might become evident during tachycardia because tachycardia reduces coronary flow reserve and facilitates the production of myocardial ischemia.
METHODS: Doppler phasic left coronary flow velocity pattern was obtained at rest and during tachycardia in 23 patients without coronary stenosis. The time constant of left ventricular isovolumic pressure (tau) was used to assess ventricular relaxation.
RESULTS: The time to peak flow velocity of the diastolic coronary flow wave was longer, and the fraction of the first third of diastolic coronary flow was smaller, in patients with a longer tau (r = 0.58, p < 0.01; r = -0.44, p < 0.05), indicating a close relation between early diastolic coronary flow dynamics and ventricular relaxation. Although rapid atrial pacing yielded an increase in the coronary flow velocity integral per minute in all patients, diastolic coronary flow velocity integral per minute increased in 9 patients with a normal (< or = 40 ms) tau at rest but decreased in 14 patients with a longer (> 40 ms) tau at rest.
CONCLUSIONS: Impaired left ventricular relaxation was associated with decreased coronary flow in early diastole at rest and decreased coronary flow throughout diastole during tachycardia in patients without coronary stenosis. These findings may provide more insight into the mechanism of tachycardia-induced subendocardial ischemia in patients with impaired ventricular relaxation but without concomitant coronary stenosis.

Entities:  

Mesh:

Year:  1994        PMID: 7963107     DOI: 10.1016/0735-1097(94)90166-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  NADH changes during hypoxia, ischemia, and increased work differ between isolated heart preparations.

Authors:  Anastasia M Wengrowski; Sarah Kuzmiak-Glancy; Rafael Jaimes; Matthew W Kay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-13       Impact factor: 4.733

Review 2.  Nonacute coronary syndrome anginal chest pain.

Authors:  Megha Agarwal; Puja K Mehta; C Noel Bairey Merz
Journal:  Med Clin North Am       Date:  2010-03       Impact factor: 5.456

3.  Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.

Authors:  Aish Sinha; Haseeb Rahman; Andrew Webb; Ajay M Shah; Divaka Perera
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 35.855

4.  Coronary microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure.

Authors:  P L Van Herck; S G Carlier; M J Claeys; S E Haine; P Gorissen; H Miljoen; J M Bosmans; C J Vrints
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

5.  Risk factors of postoperative major adverse cardiac events after radical cystectomy: implication of diastolic dysfunction.

Authors:  In-Jung Jun; Junghwa Kim; Hyun-Gyu Kim; Gi-Ho Koh; Jai-Hyun Hwang; Young-Kug Kim
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

6.  Prognostic value of left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease.

Authors:  Hidekatsu Fukuta; Nobuyuki Ohte; Kazuaki Wakami; Toshihiko Goto; Tomomitsu Tani; Genjiro Kimura
Journal:  Cardiol Res Pract       Date:  2012-04-12       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.